Publication:
Administration of rectal cytotec versus rectal buscopan before hysteroscopy

dc.contributor.authorGÖKMEN KARASU, AYŞE FİLİZ
dc.contributor.authorGÖKMEN KARASU, AYŞE FİLİZ
dc.contributor.authorAYDIN, SERDAR
dc.contributor.authorATEŞ, SEDA
dc.contributor.authorTAKMAZ, TAHA
dc.date.accessioned2020-10-30T00:13:41Z
dc.date.available2020-10-30T00:13:41Z
dc.date.issued2020-06-01T00:00:00Z
dc.description.abstractIntroduction:Our objective was to compare the effect of rectal misoprostol (Cytotec) versus rectal hyoscine-n-butyl bromide (Buscopan) on patients undergoing hysteroscopy. We hypothesised that HBB may have a role in cervical priming. Material and methods:This trial was conducted at Bezmialem Vakif University Hospital. Women of reproductive age between 18-50 years who were scheduled for operative hysteroscopy indicated by type 1 submucous myoma or endometrial polyps were recruited for the study. Ninety patients were divided randomly into three groups. Group 1 received placebo treatment. Group 2 received rectal 200 mcg misoprostol and Group 3 received rectal 20 mg hyoscine-n-butyl bromide two hours before the procedure. Procedures were performed using a bipolar 26 F (9 mm) continuous-flow rigid resectoscope with a 30 degrees lens. The outcome measures included cervical dilation width and time, ease of cervical dilation, procedure time and operative complications. Postoperative self-rated pain was assessed one hour after the procedure. Results:Thirteen patients (43. 3%) in the placebo treatment group, 11 patients (36.7%) in the misoprostol group and four patients (13.3%) in the hyoscine-n-butyl bromide group needed analgesics postoperatively (p = .02). The mean duration of cervical dilation time was longest in Group 1 and shortest in Group 3, however this difference did not reach statistical significance (p=.11). There was no difference with regard to other studied parameters. Summary:HBB reduced the need for pain medication compared to placebo. Larger studies are needed to further investigate the role of HBB in facilitating pre-operative cervical priming.
dc.identifier.citationGÖKMEN KARASU A. F. , AYDIN S., ATEŞ S., TAKMAZ T., Comba C., -Administration of rectal cytotec versus rectal buscopan before hysteroscopy-, MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2020
dc.identifier.doi10.1080/13645706.2020.1748059
dc.identifier.pubmed32491923
dc.identifier.scopus85086857906
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27133
dc.identifier.wosWOS:000543348400001
dc.titleAdministration of rectal cytotec versus rectal buscopan before hysteroscopy
dc.typeArticle
dspace.entity.typePublication
dspace.relatedentity.typePerson
dspace.relatedentity.typePerson
dspace.relatedentity.typePerson
dspace.relatedentity.typePerson
local.avesis.idece83fb7-ebe0-4b70-9196-87cbfc5eb588
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
person.identifier.orcid0000-0001-7480-4691
person.identifier.orcid0000-0002-2043-395X
person.identifier.orcid0000-0003-0472-3727
person.identifier.orcid0000-0003-0793-2348
relation.isAuthorOfPublication64cd0679-6c73-402a-b6f8-d1ed23d953ea
relation.isAuthorOfPublicationb373a82e-047e-4e7b-b238-29e3fc44e124
relation.isAuthorOfPublication05accb91-e114-4a8a-b922-826c3a707026
relation.isAuthorOfPublication8f240941-f677-4b2b-8717-24a9667d203b
relation.isAuthorOfPublication.latestForDiscovery05accb91-e114-4a8a-b922-826c3a707026
relation.isGoalOfPublication7e7ce1dc-9556-4fa2-b604-c2ba181d38b9
relation.isGoalOfPublication.latestForDiscovery7e7ce1dc-9556-4fa2-b604-c2ba181d38b9

Files